Immediate Effects of TENS and HVPS on Subacromial Pain and Shoulder Movements

NCT ID: NCT03588143

Last Updated: 2018-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

106 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-30

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was performed to investigate the immediate effects of transcutaneous electrical nerve stimulation (TENS) and high voltage pulsed stimulation (HVPS) on resting pain and pain-free range of shoulder motion (pfROM) in patients with subacromial pain syndrome (SAPS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Transcutaneous electrical stimulation (TENS) and high voltage pulsed current/stimulation (HVPS) are both electrotherapeutic agents which can be used for pain relief in musculoskeletal conditions. Standard TENS devices usually deliver biphasic pulsed currents with a pulse duration between 50 μs and 1000 μs and pulse frequencies between 1 and 250 pps. HVPS devices are TENS-like devices which deliver direct current with twin monophasic spiked pulses of 10-500 V (500-ohm load) with a short pulse duration (microseconds). In both conventional TENS technique and HVPS for pain relief, the aim is to activate spinal gating mechanism by selectively stimulating large diameter Aβ fibers. Theoretically, high-frequency (\~10-250 pps), low-intensity (nonpainful) currents are most efficient in selectively activating Aβ fibers, which is practically recognized by the user reporting 'strong but comfortable' nonpainful electrical paresthesia beneath the electrodes. There is no available evidence for the efficacy of TENS in patients with subacromial pain. Also, there has been little experimental work on the effects of HVPS on pain relief in the literature, as well as no known study for its efficacy in SAPS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shoulder Pain Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electrical stimulation with TENS

TENS with 100 Hz frequency, 65 microseconds pulse duration, in continuous pattern

Group Type ACTIVE_COMPARATOR

Electrical stimulation

Intervention Type DEVICE

Two kinds of electrical stimulation (TENS and HVPS) and placebo intervention

Electrical stimulation with HVPS

HVPS with twin spiked monophasic current at 100 pps frequency, in continuous pattern

Group Type EXPERIMENTAL

Electrical stimulation

Intervention Type DEVICE

Two kinds of electrical stimulation (TENS and HVPS) and placebo intervention

Placebo electrical stimulation

same electrode placement with other interventions, using the same electrotherapy device, without activating the device except its time unit.

Group Type PLACEBO_COMPARATOR

Electrical stimulation

Intervention Type DEVICE

Two kinds of electrical stimulation (TENS and HVPS) and placebo intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrical stimulation

Two kinds of electrical stimulation (TENS and HVPS) and placebo intervention

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TENS HVPS Placebo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-65 years-old
* Pain with active shoulder movements
* Subacromial pain for 2 weeks-2 months
* Positive Hawkins-Kennedy and painful arc tests, infraspinatus weakness; in addition to these, for patients with partial rotator cuff tear, a negative drop-arm test
* Neer stage 1-2

Exclusion Criteria

* Radiologically confirmed malignity
* Acromial/acromioclavicular arthritis
* History of fracture or surgery in the affected shoulder-arm complex
* Clinically confirmed polyarthritis, rheumatoid arthritis, fibromyalgia, adhesive capsulitis or osteoarthritis of glenohumeral joint or subacromial region
* Cervical/thoracal spinal problem• Neurological problems which may affect upper extremity movements or pain perception (stroke, peripheral neuropathy, brachial plexus lesion, etc.)
* Neer stage 3 and indication for surgery
* Usage of analgesic medication
* Obesity (Body mass ≥30 kg/m2)
* Contraindications for TENS or HVPS
* Previous experience with electrophysical agents or physiotherapy
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Muğla Sıtkı Koçman University

OTHER

Sponsor Role collaborator

Mehmet Gürhan KARAKAYA

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mehmet Gürhan KARAKAYA

Principal investigator, Head of Neurological Rehabilitation Department, PT. PhD. Prof.

Responsibility Role SPONSOR_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16/044

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.